These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8828796)

  • 1. Chemical conjugation of Gly-Pro-Arg-Pro. Tetrapeptide to low molecular weight urokinase.
    Chen XC; Hua ZC; Zhu DX
    Biochem Mol Biol Int; 1996 Jun; 39(3):455-60. PubMed ID: 8828796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A low molecular weight urokinase derivative with enhanced fibrin affinity.
    Chen XC; Hua ZC; Zhu DX
    Biochem Mol Biol Int; 1996 Jul; 39(4):797-803. PubMed ID: 8843349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a recombinant chimeric plasminogen activator composed of Gly-Pro-Arg-Pro tetrapeptide and truncated urokinase-type plasminogen activator expressed in Escherichia coli.
    Hua ZC; Chen XC; Dong C; Zhu DX
    Biochem Biophys Res Commun; 1996 May; 222(2):576-83. PubMed ID: 8670247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The behaviour of urokinase and porcine kidney cell plasminogen activator towards some synthetic peptides.
    Walker B; Elmore DT
    Thromb Res; 1984 Apr; 34(2):103-7. PubMed ID: 6539512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a recombinant chimeric plasminogen activator with enhanced fibrin binding.
    Jiao J; Yu M; Ru B
    Biochim Biophys Acta; 2001 Apr; 1546(2):399-405. PubMed ID: 11295444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of reciprocal pro-urokinase/plasminogen activation--stimulation by a template formed by the urokinase receptor bound to poly(D-lysine).
    Petersen LC
    Eur J Biochem; 1997 Apr; 245(2):316-23. PubMed ID: 9151959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elastase digested urokinase (ED-UK).
    Sumi H; Kosugi T; Toki N; Mihara H
    Experientia; 1985 Dec; 41(12):1546-8. PubMed ID: 3852742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structure basis of the poor fibrin specificity of urokinase (II)--The inhibition of urokinase A chain 149-157 on the fibrin stimulated activation of plasminogen by tissue type plasminogen activator.
    Song A; Liu JN; Yu RR; Cui DF; Zhou TM; Cui HR; Zhu DX
    Sci China B; 1992 Aug; 35(8):966-73. PubMed ID: 1338753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro.
    Cassels R; Fears R; Smith RA
    Biochem J; 1987 Oct; 247(2):395-400. PubMed ID: 3122725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic studies of urokinase-catalysed hydrolysis of 5-oxo-L-prolylglycyl-L-arginine 4-nitroanilide.
    Ipsen HH; Christensen U
    Biochim Biophys Acta; 1980 Jun; 613(2):476-81. PubMed ID: 6449958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insertion of fibrin peptides into urokinase enhances fibrin affinity.
    Homandberg GA; Wai T
    Thromb Res; 1990 May; 58(4):403-12. PubMed ID: 2353345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and functional characterization of mutants of recombinant single-chain urokinase-type plasminogen activator obtained by site-specific mutagenesis of Lys158, Ile159 and Ile160.
    Lijnen HR; Nelles L; Van Hoef B; Demarsin E; Collen D
    Eur J Biochem; 1988 Nov; 177(3):575-82. PubMed ID: 2973984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The construction and expression of chimeric urokinase-type plasminogen activator genes containing kringle domains of human plasminogen.
    Boutaud A; Castellino FJ
    Arch Biochem Biophys; 1993 Jun; 303(2):222-30. PubMed ID: 8512311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activation by pro-urokinase in complex with its receptor--dependence on a tripeptide (Spectrozyme plasmin).
    Wang J; Mazar A; Quan N; Schneider A; Henkin J
    Eur J Biochem; 1997 Jul; 247(1):256-61. PubMed ID: 9249034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). A study in vitro and in two animal species.
    Gurewich V; Pannell R; Louie S; Kelley P; Suddith RL; Greenlee R
    J Clin Invest; 1984 Jun; 73(6):1731-9. PubMed ID: 6725557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of the efficacy and specificity of tissue plasminogen activator and pro-urokinase: demonstration of synergism and of different thresholds of non-selectivity.
    Gurewich V; Pannell R
    Thromb Res; 1986 Oct; 44(2):217-28. PubMed ID: 3097872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the activation rates of plasminogen by tissue plasminogen activator and urokinase.
    Takada A; Shizume K; Cho M; Takada Y
    Thromb Res; 1987 Feb; 45(4):371-81. PubMed ID: 2437668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen-independent initiation of the pro-urokinase activation cascade in vivo. Activation of pro-urokinase by glandular kallikrein (mGK-6) in plasminogen-deficient mice.
    List K; Jensen ON; Bugge TH; Lund LR; Ploug M; Danø K; Behrendt N
    Biochemistry; 2000 Jan; 39(3):508-15. PubMed ID: 10642175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific fibrinolytic properties of different molecular forms of pro-urokinase from a monkey kidney cell culture.
    Rijken DC; Binnema DJ; Los P
    Thromb Res; 1986 Jun; 42(6):761-8. PubMed ID: 2425448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cleavage of pro-urokinase type plasminogen activator by stromelysin-1.
    Orgel D; Schröder W; Hecker-Kia A; Weithmann KU; Kolkenbrock H; Ulbrich N
    Clin Chem Lab Med; 1998 Sep; 36(9):697-702. PubMed ID: 9804393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.